Client News
ViGeneron Announces First Patient Dosed in Phase 1b Clinical Trial of VG901 for the Intravitreal Treatment of Retinitis Pigmentosa
Mainz Biomed Reports Full Year 2023 Financial Results
G.ST Antivirals Reports Start of Phase II Trial and Announces Appointment of Ronald Bruce Turner as New Chief Medical Officer
Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024
Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
neurocare group AG Welcomes Norman Erhard as Senior VP Europe & Latin America
Medigene AG Secures European Patent for its iM-TCR Technology
iOmx Therapeutics to present new data on lead programs and I/O target screening platform at AACR 2024